サマリー

副鼻腔拡張器具の世界市場は、2022年の28億米ドルから2027年には38億米ドルに達すると予測され、予測期間中のCAGRは6.6%となります。市場の成長は、主に慢性副鼻腔炎の拡大やバルーン副鼻腔形成術などの低侵襲手術の上昇傾向などの要因によって推進されています。


"副鼻腔ステント/インプラントは2022年から2027年にかけて最高のCAGR 8.2%で成長すると予測される"

副鼻腔拡張器具市場は、製品に基づき、バルーン副鼻腔拡張器具、内視鏡（サイナスコープ、ライノスコープ）、副鼻腔ステント/インプラント、ハンドヘルド器具に分類されます。この市場の成長は、従来の内視鏡下副鼻腔手術と比較してバルーン拡張処置の利点や慢性副鼻腔炎における規則性の上昇といった要因によって大きく左右されます。

"アジア太平洋地域は、予測期間中に最も高いCAGRを記録すると推定される。"

このレポートでは、副鼻腔拡張装置市場は、北米、ヨーロッパ、アジア太平洋、および世界の残りの部分（RoW）など、4つの重要な地域セグメントに分岐されています。アジア太平洋地域の市場は、予測期間中に最も高い成長率を記録すると予測されています。この市場の成長は、主に老年人口の増加、一人当たりの所得の増加、低コストの治療法の存在に牽引されています。

供給側の一次面接の内訳、企業タイプ、呼称、地域別。

- 企業タイプ別Tier 1 (32%) , Tier 2 (44%) , Tier 3 (24%)

- 役職別Cレベル (30%)、ディレクターレベル (34%)、その他 (36%)

- 地域別北米（40％）、欧州（28％）、アジア太平洋（20％）、その他の地域（12％）。


レポート掲載企業一覧

- アクラレント社（ジョンソン・エンド・ジョンソン社子会社）（米国）
- オリンパス株式会社（日本）
- エンテルス・メディカル・インク（ストライカー子会社）（米国）
- メドトロニック・ピーエルシー(アイルランド)
- スミス・アンド・ネフュー plc（英国）
- インターセクトENT, Inc.（米国）
- シヌシス・コーポレーション(米国)
- InnAccel Pvt.Ltd（インド）
- MERIL LIFE SCIENCES PVT Ltd.（インド） MERIL LIFE SCIENCES PVT Ltd.(インド)
- オプティムLLC（米国）
- EMOS Technology GmbH（ドイツ）
- KARL STORZ（ドイツ）
- ペンタックスメディカル（日本）
- Sklar Surgical Instruments(アメリカ)
- ダレントメディカル(米国)
- Angiplast Pvt.Ltd.(インド)
- サミット・メディカルLLC.(アメリカ)
- リチャード・ウルフGmbH（ドイツ）
- エンターメッド（ドイツ）
- SCHÖLLY FIBEROPTIC GMBH (ドイツ)
- XION GmbH（ドイツ）
- クックメディカル（アメリカ）
- マキサーエンドスコピーGmbH（ドイツ）
- ESC Medicams（インド）
- Jilin Coronado Medical Ltd. （中国(中国)
調査対象
本レポートでは、副鼻腔拡張装置市場を製品別、地域別に調査しています。また、市場成長に影響を与える要因（促進要因、抑制要因、機会、課題など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供しています。また、副鼻腔拡張装置市場全体に対する成長動向、展望、貢献度に関して、マイクロマーケットを調査しています。本レポートでは、4つの主要地域に関して、市場セグメントの収益を予測しています。


レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供します。

- 市場の浸透。副鼻腔拡張装置市場の上位25社が提供する副鼻腔拡張装置に関する包括的な情報。副鼻腔拡張装置市場を製品別、地域別に分析したレポートです。

- 市場開発。有利な新興市場に関する包括的な情報を提供します。本レポートでは、主要な地域ごとの各種固定装置市場を分析しています。

- 市場の多様化。副鼻腔拡張装置市場における未開拓の地域、最近の開発、投資に関する徹底的な情報。

- 競争力のある評価。副鼻腔拡張装置市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る

目次

1 INTRODUCTION 25
1.1 STUDY OBJECTIVES 25
1.2 MARKET DEFINITION 25
1.2.1 INCLUSIONS AND EXCLUSIONS 26
1.3 MARKET SCOPE 26
1.3.1 GEOGRAPHIC SCOPE 27
1.3.2 YEARS CONSIDERED 27
1.4 CURRENCY 28
1.5 LIMITATIONS 28
1.6 MARKET STAKEHOLDERS 28
1.7 SUMMARY OF CHANGES 29
2 RESEARCH METHODOLOGY 30
2.1 RESEARCH DATA 30
FIGURE 1 RESEARCH DESIGN 30
2.1.1 SECONDARY DATA 31
2.1.1.1 Secondary sources 32
2.1.2 PRIMARY DATA 32
FIGURE 2 PRIMARY SOURCES 32
2.1.2.1 Key data from primary sources 33
2.1.2.2 Key industry insights 34
2.1.2.3 Breakdown of primary interviews 34
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 34
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 35
2.2 MARKET SIZE ESTIMATION 35
FIGURE 5 REVENUE SHARE ANALYSIS ILLUSTRATION FOR JOHNSON & JOHNSON 37
FIGURE 6 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 37
FIGURE 7 MARKET SIZE ESTIMATION FROM PARENT MARKET 38
2.2.1 GROWTH FORECAST 39
FIGURE 8 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 39
FIGURE 9 TOP-DOWN APPROACH 41
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 42
FIGURE 10 DATA TRIANGULATION METHODOLOGY 42
2.4 MARKET SHARE ANALYSIS 43
2.5 STUDY ASSUMPTIONS 43
2.6 RISK ASSESSMENT 43
TABLE 1 RISK ASSESSMENT 43
3 EXECUTIVE SUMMARY 44
FIGURE 11 SINUS DILATION DEVICES MARKET, BY PRODUCT,
2022 VS. 2027 (USD MILLION) 44
FIGURE 12 ENDOSCOPES MARKET, BY TYPE, 2022 VS. 2027 (USD MILLION) 45
FIGURE 13 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE,
2022 VS. 2027 (USD MILLION) 45
FIGURE 14 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING,
2022 VS. 2027 (USD MILLION) 46
FIGURE 15 SINUS DILATION DEVICES MARKET, BY PROCEDURE,
2022 VS. 2027 (USD MILLION) 46
FIGURE 16 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET 47
4 PREMIUM INSIGHTS 48
4.1 SINUS DILATION DEVICES MARKET OVERVIEW 48
FIGURE 17 HIGH PREVALENCE OF CHRONIC SINUSITIS TO DRIVE MARKET 48
4.2 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2022–2027 48
FIGURE 18 HOSPITALS AND ASCS SEGMENT TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 48
4.3 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT AND COUNTRY (2022) 49
FIGURE 19 BALLOON SINUS DILATION DEVICES SEGMENT TO DOMINATE ASIA PACIFIC MARKET IN 2022 49
4.4 GEOGRAPHIC SNAPSHOT OF SINUS DILATION DEVICES MARKET 50
FIGURE 20 CHINA TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 50
5 MARKET OVERVIEW 51
5.1 INTRODUCTION 51
5.2 MARKET DYNAMICS 51
FIGURE 21 SINUS DILATION DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 51
5.2.1 DRIVERS 52
5.2.1.1 High prevalence of chronic sinusitis 52
5.2.1.2 Benefits of balloon dilation procedures over traditional endoscopic sinus surgeries 52
5.2.1.3 Growing preference for minimally invasive surgeries 54
5.2.1.4 Rising healthcare expenditure 54
FIGURE 22 CURRENT HEALTH EXPENDITURE PER CAPITA 54
FIGURE 23 CURRENT HEALTH EXPENDITURE (% OF GDP) 55
5.2.1.5 Increasing availability of reimbursements 55
 
5.2.2 RESTRAINTS 57
5.2.2.1 Risks associated with sinus surgeries 57
5.2.2.2 Availability of non-surgical treatments for chronic sinusitis 57
5.2.3 OPPORTUNITIES 58
5.2.3.1 Growing healthcare market in emerging economies 58
FIGURE 24 GROWTH IN CURRENT HEALTHCARE EXPENDITURE PER CAPITA IN BRIC COUNTRIES, 2012–2019 60
5.2.4 CHALLENGES 60
5.2.4.1 Dearth of skilled otolaryngologists, ENT surgeons, and endoscopists 60
5.2.4.2 Survival of small players and new entrants 61
5.3 RANGES/SCENARIOS 61
FIGURE 25 PESSIMISTIC SCENARIO 61
FIGURE 26 OPTIMISTIC SCENARIO 62
FIGURE 27 REALISTIC SCENARIO 62
5.4 VALUE CHAIN ANALYSIS 63
FIGURE 28 VALUE CHAIN ANALYSIS: MAJOR VALUE IS ADDED DURING MANUFACTURING AND ASSEMBLY PHASE 63
5.5 SUPPLY CHAIN ANALYSIS 65
FIGURE 29 DIRECT DISTRIBUTION—PREFERRED STRATEGY FOR PROMINENT COMPANIES 66
5.6 TECHNOLOGY ANALYSIS 66
TABLE 2 BENEFITS OF ENDOSCOPIC PROCEDURE 68
5.7 PORTER’S FIVE FORCES ANALYSIS 69
5.7.1 THREAT OF NEW ENTRANTS 69
5.7.2 INTENSITY OF COMPETITIVE RIVALRY 69
5.7.3 BARGAINING POWER OF BUYERS 69
5.7.4 BARGAINING POWER OF SUPPLIERS 69
5.7.5 THREAT OF SUBSTITUTES 69
5.8 KEY STAKEHOLDERS AND BUYING CRITERIA 71
5.8.1 KEY STAKEHOLDERS IN BUYING PROCESS 71
FIGURE 30 INFLUENCE OF STAKEHOLDERS IN BUYING PROCESS FOR END USERS 71
TABLE 3 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR END USERS (%) 71
5.8.2 BUYING CRITERIA 71
FIGURE 31 KEY BUYING CRITERIA FOR END USERS 71
TABLE 4 KEY BUYING CRITERIA FOR END USERS 72
5.9 REGULATORY LANDSCAPE 72
TABLE 5 REGULATORY AUTHORITIES GOVERNING SINUS DILATION DEVICES MARKET 72
5.10 PATENT ANALYSIS 76
5.11 KEY CONFERENCES AND EVENTS 77
TABLE 6 LIST OF CONFERENCES AND EVENTS, 2022–2023 77
5.12 PRICING ANALYSIS 78
TABLE 7 PRICE RANGE FOR SINUS DILATION DEVICES 78
5.13 TRADE ANALYSIS 78
TABLE 8 NUMBER OF EXPORTS AND IMPORTS RELATED TO ENDOSCOPY EQUIPMENT 78
5.14 ECOSYSTEM ANALYSIS 79
TABLE 9 ROLE IN ECOSYSTEM 79
FIGURE 32 KEY PLAYERS OPERATING IN SINUS DILATION DEVICES MARKET 81
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
6 SINUS DILATION DEVICES MARKET, BY PRODUCT 82
6.1 INTRODUCTION 83
TABLE 10 SINUS DILATION DEVICES MARKET, BY PRODUCT,
2020–2027 (USD MILLION) 83
6.2 BALLOON SINUS DILATION DEVICES 83
6.2.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE SURGICAL PROCEDURES TO SUPPORT MARKET 83
TABLE 11 BALLOON SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 84
6.3 ENDOSCOPES 84
TABLE 12 ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 84
TABLE 13 ENDOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 85
6.3.1 SINUSCOPES 85
6.3.1.1 Largest and fastest-growing segment of endoscopes market 85
TABLE 14 SINUSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 85
6.3.2 RHINOSCOPES 86
6.3.2.1 Primarily used to examine nasal cavity and passage 86
TABLE 15 RHINOSCOPES MARKET, BY REGION, 2020–2027 (USD MILLION) 86
6.4 SINUS STENTS/IMPLANTS 87
6.4.1 SINUS STENTS/IMPLANTS ARE USED POSTOPERATIVELY FOLLOWING AN ENDOSCOPIC SINUS SURGERY 87
TABLE 16 SINUS STENTS/IMPLANTS MARKET, BY REGION, 2020–2027 (USD MILLION) 87
6.5 HANDHELD INSTRUMENTS 87
6.5.1 HANDHELD INSTRUMENTS ARE WIDELY USED IN ALMOST ALL KINDS OF SURGERIES 87
TABLE 17 HANDHELD INSTRUMENTS MARKET, BY REGION, 2020–2027 (USD MILLION) 89
7 SINUS DILATION DEVICES MARKET, BY PROCEDURE 90
7.1 INTRODUCTION 91
TABLE 18 SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 91
 
7.2 STANDALONE SINUS DILATION PROCEDURES 91
7.2.1 STANDALONE SINUS DILATION PROCEDURES ARE WIDELY USED FOR SINUS DILATION 91
TABLE 19 STANDALONE SINUS DILATION PROCEDURES MARKET, BY REGION,
2020–2027 (USD MILLION) 92
7.3 HYBRID SINUS DILATION PROCEDURES 92
7.3.1 HYBRID SINUS DILATION PROCEDURES ARE MORE INVASIVE IN NATURE COMPARED TO STANDALONE PROCEDURES 92
TABLE 20 NUMBER OF SINUS PROCEDURES PERFORMED IN ENGLAND BETWEEN
2010 AND 2019 93
TABLE 21 HYBRID SINUS DILATION PROCEDURES MARKET, BY REGION,
2020–2027 (USD MILLION) 93
8 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE 94
8.1 INTRODUCTION 95
TABLE 22 SINUS DILATION DEVICES MARKET, BY PATIENT TYPE,
2020–2027 (USD MILLION) 95
8.2 ADULT PATIENTS 95
8.2.1 ADULT PATIENTS DOMINATE MARKET 95
FIGURE 33 THE PERCENTAGE DISTRIBUTION OF CHRONIC SINUSITIS BY AGE GROUP. 95
TABLE 23 ADULT SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 97
8.3 PEDIATRIC PATIENTS 97
8.3.1 HIGH PREVALENCE OF SINUSITIS IN CHILDREN TO DRIVE MARKET 97
FIGURE 34 TIME OF ONSET OF CRS TO THE FIRST SURGICAL INTERVENTION FOR ENDOSCOPIC SINUS SURGERY PATIENTS. 97
TABLE 24 PEDIATRIC SINUS DILATION DEVICES MARKET, BY REGION,
2020–2027 (USD MILLION) 98
9 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING 99
9.1 INTRODUCTION 100
TABLE 25 SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING,
2020–2027 (USD MILLION) 100
9.2 HOSPITALS AND AMBULATORY SURGERY CENTERS 100
9.2.1 LARGEST AND FASTEST-GROWING END USERS OF SINUS DILATION DEVICES 100
TABLE 26 SINUS DILATION DEVICES MARKET FOR HOSPITALS AND AMBULATORY SURGERY CENTERS, BY REGION, 2020–2027 (USD MILLION) 101
9.3 ENT CLINICS 101
9.3.1 FASTER RECOVERY TIME AND COST-EFFECTIVENESS ARE SUPPORTING SEGMENT GROWTH 101
TABLE 27 SINUS DILATION DEVICES MARKET FOR ENT CLINICS, BY REGION,
2020–2027 (USD MILLION) 101
 
10 SINUS DILATION DEVICES MARKET, BY REGION 102
10.1 INTRODUCTION 103
TABLE 28 SINUS DILATION DEVICES MARKET, BY REGION, 2020–2027 (USD MILLION) 103
10.2 NORTH AMERICA 103
FIGURE 35 NORTH AMERICA: SINUS DILATION DEVICES MARKET SNAPSHOT 104
TABLE 29 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 104
TABLE 30 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 105
TABLE 31 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 105
TABLE 32 NORTH AMERICA: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 105
TABLE 33 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 105
TABLE 34 NORTH AMERICA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 106
10.2.1 US 106
10.2.1.1 Favorable reimbursement scenario for sinus dilation procedures 106
TABLE 35 US: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 107
TABLE 36 US: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 107
TABLE 37 US: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 107
10.2.2 CANADA 107
10.2.2.1 Rising geriatric population and associated increase in prevalence of CRS to support market growth 107
TABLE 38 CANADA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 108
TABLE 39 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 108
TABLE 40 CANADA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 108
10.3 EUROPE 109
TABLE 41 EUROPE: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 109
TABLE 42 EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 109
TABLE 43 EUROPE: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 110
TABLE 44 EUROPE: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 110
TABLE 45 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 110
TABLE 46 EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 110
10.3.1 GERMANY 111
10.3.1.1 Rising geriatric population and increasing R&D—key factors driving market 111
TABLE 47 GERMANY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 111
TABLE 48 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 112
TABLE 49 GERMANY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 112
10.3.2 UK 112
10.3.2.1 Fastest-growing market for sinus dilation devices in Europe 112
TABLE 50 UK: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 113
TABLE 51 UK: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 113
TABLE 52 UK: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 113
10.3.3 FRANCE 114
10.3.3.1 High burden of chronic sinusitis to drive market 114
TABLE 53 FRANCE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 114
TABLE 54 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 114
TABLE 55 FRANCE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 115
10.3.4 ITALY 115
10.3.4.1 Growing geriatric population to support adoption of sinus dilation devices 115
TABLE 56 ITALY: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 115
TABLE 57 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 117
TABLE 58 ITALY: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 117
10.3.5 SPAIN 117
10.3.5.1 Rising healthcare expenditure to support market for sinus dilation devices 117
TABLE 59 SPAIN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 118
TABLE 60 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 118
TABLE 61 SPAIN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 118
10.3.6 REST OF EUROPE 118
TABLE 62 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 119
TABLE 63 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 119
TABLE 64 REST OF EUROPE: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 119
10.4 ASIA PACIFIC 120
FIGURE 36 ASIA PACIFIC: SINUS DILATION DEVICES MARKET SNAPSHOT 121
TABLE 65 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY COUNTRY, 2020–2027 (USD MILLION) 121
TABLE 66 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 122
TABLE 67 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 122
TABLE 68 ASIA PACIFIC: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 122
TABLE 69 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 122
TABLE 70 ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 123
10.4.1 CHINA 123
10.4.1.1 Fastest-growing market for sinus dilation devices 123
TABLE 71 CHINA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 123
TABLE 72 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 124
TABLE 73 CHINA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 124
10.4.2 JAPAN 124
10.4.2.1 Large geriatric population to aid market growth 124
TABLE 74 JAPAN: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 125
TABLE 75 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 125
TABLE 76 JAPAN: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 125
10.4.3 INDIA 125
10.4.3.1 High prevalence of sinusitis will drive demand for sinus dilation devices 125
TABLE 77 INDIA: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 126
TABLE 78 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 126
TABLE 79 INDIA: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 126
10.4.4 REST OF ASIA PACIFIC 126
TABLE 80 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 127
TABLE 81 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 127
TABLE 82 REST OF ASIA PACIFIC: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 128
10.5 REST OF THE WORLD 128
TABLE 83 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PRODUCT, 2020–2027 (USD MILLION) 128
TABLE 84 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PROCEDURE, 2020–2027 (USD MILLION) 129
TABLE 85 REST OF THE WORLD: ENDOSCOPES MARKET, BY TYPE, 2020–2027 (USD MILLION) 129
TABLE 86 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT CARE SETTING, 2020–2027 (USD MILLION) 129
TABLE 87 REST OF THE WORLD: SINUS DILATION DEVICES MARKET, BY PATIENT TYPE, 2020–2027 (USD MILLION) 129
11 COMPETITIVE LANDSCAPE 131
11.1 OVERVIEW 131
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 131
TABLE 88 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN SINUS DILATION DEVICES MARKET 131
11.3 REVENUE SHARE ANALYSIS 132
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN SINUS DILATION DEVICES MARKET 132
11.4 MARKET SHARE ANALYSIS 132
TABLE 89 SINUS DILATION DEVICES MARKET: DEGREE OF COMPETITION 133
11.5 COMPANY EVALUATION QUADRANT 134
11.5.1 STARS 134
11.5.2 EMERGING LEADERS 134
11.5.3 PERVASIVE PLAYERS 134
11.5.4 PARTICIPANTS 134
FIGURE 38 COMPANY EVALUATION QUADRANT: SINUS DILATION DEVICES MARKET 135
11.6 COMPANY EVALUATION QUADRANT FOR SMES/STARTUPS 136
11.6.1 PROGRESSIVE COMPANIES 136
11.6.2 STARTING BLOCKS 136
11.6.3 RESPONSIVE COMPANIES 136
11.6.4 DYNAMIC COMPANIES 136
FIGURE 39 COMPANY EVALUATION MATRIX FOR SMES/STARTUPS: SINUS DILATION DEVICES MARKET 137
11.7 COMPANY FOOTPRINT ANALYSIS 138
TABLE 90 FOOTPRINT OF COMPANIES IN SINUS DILATION DEVICES MARKET 138
TABLE 91 REGIONAL FOOTPRINT OF COMPANIES 140
TABLE 92 PRODUCT FOOTPRINT OF COMPANIES 142
11.8 COMPETITIVE BENCHMARKING 144
TABLE 93 SINUS DILATION DEVICES MARKET: LIST OF KEY STARTUPS/SMES 144
11.9 COMPETITIVE SCENARIO 145
11.9.1 PRODUCT LAUNCHES/APPROVALS 145
TABLE 94 KEY PRODUCT LAUNCHES 145
11.9.2 DEALS 145
TABLE 95 KEY DEALS 145
11.9.3 OTHER DEVELOPMENTS 147
TABLE 96 OTHER KEY DEVELOPMENTS 147
12 COMPANY PROFILES 148
12.1 KEY PLAYERS 148
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
12.1.1 ENTELLUS MEDICAL, INC. (SUBSIDIARY OF STRYKER) 148
TABLE 97 STRYKER: BUSINESS OVERVIEW 148
FIGURE 40 STRYKER: COMPANY SNAPSHOT (2021) 149
12.1.2 MEDTRONIC PLC 154
TABLE 98 MEDTRONIC PLC: BUSINESS OVERVIEW 154
FIGURE 41 MEDTRONIC PLC: COMPANY SNAPSHOT (2022) 155
12.1.3 ACCLARENT, INC. (SUBSIDIARY OF JOHNSON & JOHNSON) 159
TABLE 99 JOHNSON & JOHNSON: BUSINESS OVERVIEW 159
FIGURE 42 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2021) 160
12.1.4 SMITH & NEPHEW PLC 163
TABLE 100 SMITH & NEPHEW PLC: BUSINESS OVERVIEW 163
FIGURE 43 SMITH & NEPHEW PLC: COMPANY SNAPSHOT (2021) 164
12.1.5 INTERSECT ENT, INC. 166
TABLE 101 INTERSECT ENT, INC.: BUSINESS OVERVIEW 166
FIGURE 44 INTERSECT ENT, INC.: COMPANY SNAPSHOT (2021) 166
12.1.6 OLYMPUS CORPORATION 169
TABLE 102 OLYMPUS CORPORATION: BUSINESS OVERVIEW 169
FIGURE 45 OLYMPUS CORPORATION: COMPANY SNAPSHOT (2022) 170
12.1.7 SINUSYS CORPORATION 173
TABLE 103 SINUSYS CORPORATION: BUSINESS OVERVIEW 173
12.1.8 INNACCEL TECHNOLOGIES PVT LTD. 174
TABLE 104 INNACCEL TECHNOLOGIES PVT LTD.: BUSINESS OVERVIEW 174
12.1.9 MERIL LIFE SCIENCES PVT. LTD. 175
TABLE 105 MERIL LIFE SCIENCES PVT. LTD.: BUSINESS OVERVIEW 175
12.1.10 OPTIM LLC 176
TABLE 106 OPTIM LLC: BUSINESS OVERVIEW 176
12.2 OTHER PLAYERS 177
12.2.1 JILIN CORONADO MEDICAL LTD. 177
TABLE 107 JILIN CORONADO MEDICAL LTD.: BUSINESS OVERVIEW 177
12.2.2 DALENT MEDICAL 178
TABLE 108 DALENT MEDICAL: BUSINESS OVERVIEW 178
12.2.3 EMOS TECHNOLOGY GMBH 179
TABLE 109 EMOS TECHNOLOGY GMBH: BUSINESS OVERVIEW 179
12.2.4 SKLAR SURGICAL INSTRUMENTS 180
TABLE 110 SKLAR SURGICAL INSTRUMENTS: BUSINESS OVERVIEW 180
12.2.5 KARL STORZ 181
TABLE 111 KARL STORZ: BUSINESS OVERVIEW 181
12.2.6 PENTAX MEDICAL 182
TABLE 112 PENTAX MEDICAL: BUSINESS OVERVIEW 182
12.2.7 ANGIPLAST PVT. LTD. 183
TABLE 113 ANGIPLAST PVT. LTD.: BUSINESS OVERVIEW 183
12.2.8 SUMMIT MEDICAL LLC 184
TABLE 114 SUMMIT MEDICAL LLC: BUSINESS OVERVIEW 184
12.2.9 RICHARD WOLF GMBH 185
TABLE 115 RICHARD WOLF GMBH: BUSINESS OVERVIEW 185
12.2.10 ENTERMED 186
TABLE 116 ENTERMED: BUSINESS OVERVIEW 186
12.2.11 SCHÖLLY FIBEROPTIC GMBH 187
TABLE 117 SCHÖLLY FIBEROPTIC GMBH: BUSINESS OVERVIEW 187
12.2.12 XION GMBH 188
TABLE 118 XION GMBH: BUSINESS OVERVIEW 188
12.2.13 COOK MEDICAL 189
TABLE 119 COOK MEDICAL: BUSINESS OVERVIEW 189
12.2.14 MAXER ENDOSCOPY GMBH 190
TABLE 120 MAXER ENDOSCOPY GMBH: BUSINESS OVERVIEW 190
12.2.15 ESC MEDICAMS 191
TABLE 121 ESC MEDICAMS: BUSINESS OVERVIEW 191
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
 
13 APPENDIX 192
13.1 INDUSTRY INSIGHTS 192
13.2 DISCUSSION GUIDE 193
13.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 197
13.4 CUSTOMIZATION OPTIONS 199
13.5 RELATED REPORTS 199
13.6 AUTHOR DETAILS 200